Search - tctmd.com

Displaying 61 - 80 of 82

Sort: Relevancy | Date

Presentation TVT 2015

Should All Repositionable Valves Have Intraprocedural TEE?

Presenter: Ian T. Meredith

June 06, 2015

Presentation TVT 2015

Impact of Second-Generation TAVR on Preprocedural Imaging

Presenter: Hasan Jilaihawi

June 06, 2015

Presentation TVT 2015

Procedural Guidance by TEE: Do We Really Need Fluoroscopy and Contrast?

Presenter: Rebecca T. Hahn

June 06, 2015

Presentation TVT 2015

Assessment for the Need for Postdeployment Dilatation or an Additional Transcatheter Valve: TEE Guidance, Hemodynamics, or Both

Presenter: Jean Buitheiu

June 06, 2015

Presentation TVT 2015

Case Examples: Medtronic Guidance vs Local CT Assessment Explaining the Occasional Discordance

Presenter: Jeffrey J. Popma

June 06, 2015

Presentation TVT 2015

When Do We Take the LVOT Into Account in Device Sizing and Why

Presenter: Hasan Jilaihawi

June 06, 2015

Presentation TVT 2015

The Best Point in RR to Measure and Why

Presenter: Jonathon A. Leipsic

June 06, 2015

Presentation TVT 2015

CT Guidance for Valve Selection: Balloon-Expandable vs Self-Expanding Valves

Presenter: Danny Dvir

June 06, 2015

Presentation TVT 2015

CT Guidance in Selecting Valve Size When at the Extremes of the Sizing Algorithm: Go Big or Go Small

Presenter: Philipp Blanke

June 06, 2015

Presentation TVT 2015

Area vs Perimeter: What Is the Rationale Between the Edwards and CoreValve Sizing Methods?

Presenter: Jonathon A. Leipsic

June 06, 2015

Presentation TVT 2015

Nuances of Preprocedure TEE That Can Provide Guidance for TAVR Success/Challenge

Presenter: Rebecca T. Hahn

June 06, 2015

Presentation Fellows 2015

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Presenter: Manish A. Parikh, Roxana Mehran

May 15, 2015

Presentation Fellows 2015

Antiplatelet Therapy for the Interventionalist

Presenter: Manish A. Parikh, Roxana Mehran, Gregg W. Stone

May 15, 2015

Presentation TCT 2014

Gene Therapy to Reverse Remodel the Failing Heart: State of the Art

Presenter: Vasken Dilsizian, Sunil V. Rao, Jose P.S. Henriques, Krisztina Zsebo

September 15, 2014

Presentation Cell Therapy 2014

Gene Modified EPCs for STEMI

Presenter: Michael Kutryk

January 22, 2014

Presentation TCT 2013

TCT-8. 6-month versus 12-month dual antiplatelet therapy after implantation of 2nd generation drug-eluting stents with Biolimus-eluting Versus Zotarolimus-eluting stent:...

Presenter: Byoung Kwon Lee

October 29, 2013

Presentation TCT 2013

Effective Antegrade Cardiac Gene Therapy with VEGF-B167 for Pacing-induced Dilated Cardiomyopathy in a Pre-clinical Large Animal Model of Heart Failure

Presenter: Felix Woitek

October 29, 2013

Presentation TCT 2013

The Genesis of Local Therapy: Catheter-directed Thrombolysis

Presenter: Thomas McNamara

October 27, 2013

Presentation TCT 2012

Gene Therapy for Peripheral Arterial Disease: Status Update

Presenter: Timothy Henry

October 22, 2012

Presentation

Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS

Presenter: Andr?s Kom?csi

October 01, 2012

Advertisement

Should All Repositionable Valves Have Intraprocedural TEE?

Impact of Second-Generation TAVR on Preprocedural Imaging

Procedural Guidance by TEE: Do We Really Need Fluoroscopy and Contrast?

Assessment for the Need for Postdeployment Dilatation or an Additional Transcatheter Valve: TEE Guidance, Hemodynamics, or Both

Case Examples: Medtronic Guidance vs Local CT Assessment Explaining the Occasional Discordance

When Do We Take the LVOT Into Account in Device Sizing and Why

The Best Point in RR to Measure and Why

CT Guidance for Valve Selection: Balloon-Expandable vs Self-Expanding Valves

CT Guidance in Selecting Valve Size When at the Extremes of the Sizing Algorithm: Go Big or Go Small

Area vs Perimeter: What Is the Rationale Between the Edwards and CoreValve Sizing Methods?

Nuances of Preprocedure TEE That Can Provide Guidance for TAVR Success/Challenge

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Antiplatelet Therapy for the Interventionalist

Gene Therapy to Reverse Remodel the Failing Heart: State of the Art

Gene Modified EPCs for STEMI

TCT-8. 6-month versus 12-month dual antiplatelet therapy after implantation of 2nd generation drug-eluting stents with Biolimus-eluting Versus Zotarolimus-eluting stent:...

Effective Antegrade Cardiac Gene Therapy with VEGF-B167 for Pacing-induced Dilated Cardiomyopathy in a Pre-clinical Large Animal Model of Heart Failure

The Genesis of Local Therapy: Catheter-directed Thrombolysis

Gene Therapy for Peripheral Arterial Disease: Status Update

Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content